Total Payments
$9,998
2024 Payments
$2,264
Companies
40
Transactions
427
Medicare Patients
2,805
Medicare Billing
$354,157
Payment Breakdown by Category
Food & Beverage$9,771 (97.7%)
Other$143.12 (1.4%)
Education$84.17 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,771 | 417 | 97.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $143.12 | 1 | 1.4% |
| Education | $84.17 | 5 | 0.8% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$9,998
423 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,673 | 109 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,086 | 48 | $0 (2024) |
| Janssen Biotech, Inc. | $751.49 | 34 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $620.09 | 31 | $0 (2024) |
| PFIZER INC. | $617.30 | 21 | $0 (2024) |
| Gilead Sciences, Inc. | $483.91 | 22 | $0 (2024) |
| Celgene Corporation | $307.63 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $293.34 | 10 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $283.55 | 13 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $254.48 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,264 | 84 | ABBVIE INC. ($811.27) |
| 2023 | $1,933 | 80 | ABBVIE INC. ($584.91) |
| 2022 | $1,843 | 77 | ABBVIE INC. ($461.64) |
| 2021 | $1,094 | 45 | E.R. Squibb & Sons, L.L.C. ($254.48) |
| 2020 | $142.09 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($44.59) |
| 2019 | $864.07 | 37 | AbbVie, Inc. ($128.02) |
| 2018 | $1,125 | 62 | AbbVie, Inc. ($198.73) |
| 2017 | $732.64 | 35 | AbbVie, Inc. ($258.67) |
All Payment Transactions
427 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/26/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: LIVER DISEASE | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: VIROLOGY | ||||||
| 10/31/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: GI | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $41.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/02/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.40 | General |
| Category: Neuroscience | ||||||
| 09/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 664 | 1,065 | $385,590 | $89,405 |
| 2022 | 15 | 722 | 1,341 | $508,188 | $103,610 |
| 2021 | 20 | 802 | 1,286 | $476,000 | $98,320 |
| 2020 | 19 | 617 | 671 | $321,771 | $62,823 |
Total Patients
2,805
Total Services
4,363
Medicare Billing
$354,157
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 79 | 79 | $65,235 | $17,628 | 27.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 144 | 144 | $107,991 | $16,271 | 15.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 32 | 280 | $31,080 | $11,014 | 35.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 33 | 171 | $27,360 | $8,558 | 31.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 37 | 37 | $23,673 | $6,728 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 73 | $22,557 | $6,443 | 28.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 73 | $15,338 | $4,959 | 32.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 70 | 71 | $44,975 | $4,795 | 10.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $13,700 | $3,930 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 31 | $14,193 | $3,819 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $13,103 | $3,808 | 29.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $6,180 | $1,403 | 22.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 12 | 12 | $205.00 | $49.55 | 24.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 91 | 92 | $76,944 | $19,686 | 25.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 39 | 415 | $58,930 | $17,142 | 29.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 146 | 147 | $132,458 | $15,601 | 11.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 41 | 235 | $43,945 | $12,586 | 28.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 42 | 42 | $22,908 | $8,102 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 83 | $32,785 | $7,747 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $23,760 | $5,812 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 46 | $21,022 | $5,774 | 27.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 75 | 76 | $51,452 | $5,051 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 36 | $10,080 | $2,306 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $7,245 | $1,932 | 26.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 14 | 14 | $25,522 | $1,317 | 5.2% |
About Dr. Georgia Rees-Lui, M.D
Dr. Georgia Rees-Lui, M.D is a Gastroenterology healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972540227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Georgia Rees-Lui, M.D has received a total of $9,998 in payments from pharmaceutical and medical device companies, with $2,264 received in 2024. These payments were reported across 427 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($9,771).
As a Medicare-enrolled provider, Rees-Lui has provided services to 2,805 Medicare beneficiaries, totaling 4,363 services with total Medicare billing of $354,157. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Bellevue, WA
- Active Since 06/02/2006
- Last Updated 06/21/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1972540227
Products in Payments
- STELARA (Biological) $761.91
- RINVOQ (Biological) $679.46
- ENTYVIO (Biological) $646.61
- ZENPEP (Drug) $581.55
- LINZESS (Drug) $550.71
- XELJANZ (Drug) $537.87
- DUPIXENT (Biological) $511.49
- ZEPOSIA (Drug) $443.94
- XIFAXAN (Drug) $351.17
- SKYRIZI (Biological) $347.76
- Humira (Biological) $319.56
- Entyvio (Biological) $267.32
- MAVYRET (Drug) $247.60
- TRULANCE (Drug) $170.23
- Creon (Drug) $155.04
- Cimzia (Drug) $152.24
- ESD - Core Endoscopy (Device) $143.12
- HUMIRA (Biological) $139.77
- CREON (Drug) $131.45
- DIFICID (Drug) $110.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Bellevue
Venkatachala Mohan, Md, MD
Gastroenterology — Payments: $744,268
Gastroenterology $744,268
Shie-Pon Tzung, Md Phd, MD PHD
Gastroenterology — Payments: $39,955
Gastroenterology $39,955
Robert Wohlman, Md, MD
Gastroenterology — Payments: $37,463
Gastroenterology $37,463
Sang Kim, M.d, M.D
Gastroenterology — Payments: $30,884
Gastroenterology $30,884
Raj Butani, M.d, M.D
Gastroenterology — Payments: $12,430
Gastroenterology $12,430
Edwin Lai, M.d, M.D
Gastroenterology — Payments: $11,715
Gastroenterology $11,715